ATC code |
ATC group/medicine or item |
| |
|
A |
ALIMENTARY TRACT AND METABOLISM |
A02 |
Drugs for acid related disorders |
A02A |
Antacids |
A02AA |
Magnesium compounds |
A02AA04 |
magnesium hydroxide |
A02AB |
Aluminium compounds |
A02AB01 |
aluminium hydroxide |
A02B |
Drugs for peptic ulcer and gastro-oesophageal reflux |
| |
disease (GORD) |
A02BA |
H2-receptor antagonists |
A02BA01 |
cimetidine |
A03 |
Drugs for functional gastrointestinal disorders |
A03B |
Belladonna and derivatives, plain |
A03BA |
Belladonna alkaloids, tertiary amines |
A03BA01 |
atropine |
A03F |
Propulsives |
A03FA |
Propulsives |
A03FA01 |
metoclopramide |
A06 |
Laxatives |
A06A |
Laxatives |
A06AB |
Contact laxatives |
A06AB06 |
senna* |
A07 |
Antidiarrheals, intestinal antiinflammatory/antiinfective |
| |
agents |
A07A |
Intestinal antiinfectives |
A07AA |
Antibiotics |
A07AA02 |
nystatin |
A07B |
Intestinal adsorbents |
A07BA |
Charcoal preparations |
A07BA01 |
charcoal, activated* |
A07C |
Electrolytes with carbohydrates |
A07CA |
oral rehydration salts* |
A07E |
Intestinal antiinflammatory agents |
A07EA |
Corticosteroids for local use |
A07EA02 |
hydrocortisone |
A07EC |
Aminosalicylic acid and similar agents |
A07EC01 |
sulfasalazine |
A10 |
Drugs used in diabetes |
A10A |
Insulins and analogues |
A10AB |
insulin injection (soluble)* |
A10AC |
insulin, intermediate-acting* |
A10B |
Oral blood glucose lowering drugs |
A10BA |
Biguanides |
A10BA02 |
metformin |
A10BB |
Sulfonamides, urea derivatives |
A10BB01 |
glibenclamide |
A11 |
Vitamins |
A11C |
Vitamin A and D, incl. combinations of the two |
A11CA |
Vitamin A, plain |
A11CA01 |
retinol |
A11CC |
Vitamin D and analogues |
A11CC01 |
ergocalciferol |
A11D |
Vitamin B1, plain and in combination with vitamin B6 and |
| |
B12 |
A11DA |
Vitamin B1, plain |
A11DA01 |
thiamine |
A11G |
Ascorbic acid (vitamin C), incl. combinations |
A11GA |
Ascorbic acid (vitamin C), plain |
A11GA01 |
ascorbic acid |
A11H |
Other plain vitamin preparations |
A11HA |
Other plain vitamin preparations |
A11HA01 |
nicotinamide |
A11HA02 |
pyridoxine |
A11HA04 |
riboflavin |
A12 |
Mineral supplements |
A12A |
Calcium |
A12AA |
Calcium |
A12AA03 |
calcium gluconate |
A12C |
Other mineral supplements |
A12CD |
Fluoride |
A12CD01 |
sodium fluoride |
A12CX |
Other mineral products |
A12CX |
iodine* |
| |
|
B |
BLOOD AND BLOOD FORMING ORGANS |
B01 |
Antithrombotic agents |
B01A |
Antithrombotic agents |
B01AA |
Vitamin K antagonists |
B01AA03 |
warfarin |
B01AB |
Heparin group |
B01AB01 |
heparin sodium* |
B01AC |
Platelet aggregation inhibitors excl. heparin |
B01AC06 |
acetylsalicylic acid |
B01AD |
Enzymes |
B01AD01 |
streptokinase |
B02 |
Antihemorrhagics |
B02B |
Vitamin K and other hemostatics |
B02BA |
Vitamin K |
B02BA01 |
phytomenadione |
B02BD |
Blood coagulation factors |
B02BD01 |
factor IX complex (coagulation factors II, VII, IX, X) |
| |
concentrate* |
B02BD02 |
factor VIII concentrate* |
B03 |
Antianemic preparations |
B03A |
Iron preparations |
B03A |
ferrous salt* |
B03AC |
Iron trivalent, parenteral preparations |
B03AC06 |
iron dextran* |
B03AD |
ferrous salt + folic acid* |
B03B |
Vitamin B12 and folic acid |
B03BA |
Vitamin B12 (cyanocobalamin and analogues) |
B03BA03 |
hydroxocobalamin |
B03BB |
Folic acid and derivatives |
B03BB01 |
folic acid |
B05 |
Blood substitutes and perfusion solutions |
B05A |
Blood and related products |
B05AA |
Blood substitutes and plasma protein fractions |
B05AA05 |
dextran 70* |
B05AA10 |
polygeline |
B05B |
I.v. solutions |
B05BA |
Solutions for parenteral nutrition |
B05BA03 |
glucose* |
B05BB |
Solutions affecting the electrolyte balance |
B05BB01 |
sodium lactate, compound solution* |
B05BB02 |
glucose with sodium chloride* |
B05BC |
Solutions producing osmotic diuresis |
B05BC01 |
mannitol |
B05D |
Peritoneal dialytics |
B05DA |
intraperitoneal dialysis solution* |
B05X |
I.v. solution additives |
B05XA |
Electrolyte solutions |
B05XA01 |
potassium chloride |
B05XA02 |
sodium hydrogen carbonate* |
B05XA03 |
sodium chloride |
B05XA05 |
magnesium sulfate |
| |
|
C |
CARDIOVASCULAR SYSTEM |
C01 |
Cardiac therapy |
C01A |
Cardiac glycosides |
C01AA |
Digitalis glycosides |
C01AA05 |
digoxin |
C01B |
Antiarrhythmics, class I and III |
C01BA |
Antiarrhythmics, class Ia |
C01BA01 |
quinidine |
C01BA02 |
procainamide |
C01BB |
Antiarrhythmics, class Ib |
C01BB01 |
lidocaine |
C01C |
Cardiac stimulants excl. cardiac glycosides |
C01CA |
Adrenergic and dopaminergic agents |
C01CA04 |
dopamine |
C01CA24 |
epinephrine |
C01D |
Vasodilators used in cardiac diseases |
C01DA |
Organic nitrates |
C01DA02 |
glyceryl trinitrate |
C01DA08 |
isosorbide dinitrate |
C02 |
Antihypertensives |
C02A |
Antiadrenergic agents, centrally acting |
C02AA |
Rauwolfia alkaloids |
C02AA02 |
reserpine |
C02AB |
Methyldopa |
C02AB01 |
methyldopa* |
C02C |
Antiadrenergic agents, peripherally acting |
C02CA |
Alpha-adrenoreceptor antagonists |
C02CA01 |
prazosin |
C02D |
Arteriolar smooth muscle, agents acting on |
C02DB |
Hydrazinophthalazine derivatives |
C02DB02 |
hydralazine |
C02DD |
Nitroferricyanide derivatives |
C02DD01 |
sodium nitroprusside* |
C03 |
Diuretics |
C03A |
Low-ceiling diuretics, thiazides |
C03AA |
Thiazides, plain |
C03AA03 |
hydrochlorothiazide |
C03C |
High-ceiling diuretics |
C03CA |
Sulfonamides, plain |
C03CA01 |
furosemide |
C03D |
Potassium-sparing agents |
C03DA |
Aldosterone antagonists |
C03DA01 |
spironolactone |
C03DB |
Other potassium-sparing agents |
C03DB01 |
amiloride |
C05 |
Vasoprotectives |
C05A |
Antihemorrhoidals for topical use |
C05A |
antihaemorrhoidal preparation: local anaesthetic, astringent, |
| |
and anti-inflammatory medicine* |
C07 |
Beta blocking agents |
C07A |
Beta blocking agents |
C07AA |
Beta blocking agents, non-selective |
C07AA05 |
propranolol |
C07AB |
Beta blocking agents, selective |
C07AB03 |
atenolol |
C08 |
Calcium channel blockers |
C08C |
Selective calcium channel blockers with mainly vascular |
| |
effects |
C08CA |
Dihydropyridine derivatives |
C08CA05 |
nifedipine |
C08D |
Selective calcium channel blockers with direct cardiac |
| |
effects |
C08DA |
Phenylalkylamine derivatives |
C08DA01 |
verapamil |
C09 |
Agents acting on the renin-angiotensin system |
C09A |
ACE inhibitors, plain |
C09AA |
ACE inhibitors, plain |
C09AA01 |
captopril |
| |
|
D |
DERMATOLOGICALS |
D01 |
Antifungals for dermatological use |
D01A |
Antifungals for topical use |
D01AA |
Antibiotics |
D01AA01 |
nystatin |
D01AC |
Imidazole and triazole derivatives |
D01AC02 |
miconazole |
D01AE |
Other antifungals for topical use |
D01AE02 |
methylrosanilinium chloride (gentian violet)* |
D01AE12 |
salicylic acid |
D01AE13 |
selenium sulfide |
D01AE20 |
benzoic acid + salicylic acid* |
D01B |
Antifungals for systemic use |
D01BA |
Antifungals for systemic use |
D01BA01 |
griseofulvin |
D02 |
Emollients and protectives |
D02A |
Emollients and protectives |
D02AB |
Zinc products |
D02AB |
calamine lotion* |
D02AE |
Carbamide products |
D02AE01 |
urea* |
D02B |
Protectives against UV-radiation |
D02BA |
Protectives against UV-radiation for topical use |
D02BA |
sun protection agent with activity against ultraviolet A and |
| |
ultraviolet B* |
D05 |
Antipsoriatics |
D05A |
Antipsoriatics for topical use |
D05AA |
coal tar* |
D05AC |
Antracen derivatives |
D05AC01 |
dithranol |
D06 |
Antibiotics and chemotherapeutics for dermatological use |
D06A |
Antibiotics for topical use |
D06AX |
Other antibiotics for topical use |
D06AX30 |
neomycin + bacitracin* |
D06B |
Chemotherapeutics for topical use |
D06BA |
Sulfonamides |
D06BA01 |
silver sulfadiazine |
D06BB |
Antivirals |
D06BB04 |
podophyllum resin* |
D07 |
Corticosteroids, dermatological preparations |
D07A |
Corticosteroids, plain |
D07AA |
Corticosteroids, weak (group I) |
D07AA02 |
hydrocortisone |
D07AC |
Corticosteroids, potent (group III) |
D07AC01 |
betamethasone |
D08 |
Antiseptics and disinfectants |
D08A |
Antiseptics and disinfectants |
D08AC |
Biguanides and amidines |
D08AC02 |
chlorhexidine |
D08AE |
Phenol and derivatives |
D08AE05 |
chloroxylenol |
D08AG |
Iodine products |
D08AG02 |
polyvidone iodine* |
D08AL |
Silver compounds |
D08AL01 |
silver nitrate |
D08AX |
Other antiseptics and disinfectants |
D08AX |
chlorine base compound* |
D08AX06 |
potassium permanganate |
D08AX08 |
ethanol |
D08AX09 |
glutaral |
D10 |
Anti-acne preparations |
D10A |
Anti-acne preparations for topical use |
D10AE |
Peroxides |
D10AE01 |
benzoyl peroxide |
D10AX |
Other anti-acne preparations for topical use |
D10AX05 |
aluminium diacetate |
| |
|
G |
GENITO URINARY SYSTEM AND SEX HORMONES |
G01 |
Gynecological antiinfectives and antiseptics |
G01A |
Antiinfectives and antiseptics, excl. combinations with |
| |
corticosteroids |
G01AA |
Antibiotics |
G01AA01 |
nystatin |
G02 |
Other gynecologicals |
G02A |
Oxytocics |
G02AB |
Ergot alkaloids |
G02AB03 |
ergometrine |
G02B |
Contraceptives for topical use |
G02BA |
Intrauterine contraceptives |
G02BA02 |
copper-containing intrauterine device* |
G02BB |
Intravaginal contraceptives |
G02BB |
diaphragms with spermicide (nonoxinol)* |
G03 |
Sex hormones and modulators of the genital system |
G03A |
Hormonal contraceptives for systemic use |
G03AA |
Progestogens and estrogens, fixed combinations |
G03AA05 |
ethinylestradiol + norethisterone* |
G03AB |
Progestogens and estrogens, sequential preparations |
G03AB03 |
ethinylestradiol + levonorgestrel* |
G03AC |
Progestogens |
G03AC01 |
norethisterone enantate* |
G03AC03 |
levonorgestrel |
G03AC06 |
medroxyprogesterone acetate* |
G03B |
Androgens |
G03BA |
3-Oxoandrosten (4) derivatives |
G03BA03 |
testosterone |
G03C |
Estrogens |
G03CA |
Natural and semisynthetic estrogens, plain |
G03CA01 |
ethinylestradiol |
G03D |
Progestogens |
G03DC |
Estren derivatives |
G03DC02 |
norethisterone |
G03G |
Gonadotropins and other ovulation stimulants |
G03GB |
Ovulation stimulants, synthetic |
G03GB02 |
clomifene |
| |
|
H |
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX |
| |
HORMONES AND INSULINS |
H01 |
Pituitary, hypothalamic hormones and analogues |
H01B |
Posterior pituitary lobe hormones |
H01BA |
Vasopressin and analogues |
H01BA02 |
desmopressin |
H01BB |
Oxytocin and analogues |
H01BB02 |
oxytocin |
H02 |
Corticosteroids for systemic use |
H02A |
Corticosteroids for systemic use, plain |
H02AA |
Mineralocorticoids |
H02AA02 |
fludrocortisone |
H02AB |
Glucocorticoids |
H02AB02 |
dexamethasone |
H02AB06 |
prednisolone |
H02AB09 |
hydrocortisone |
H03 |
Thyroid therapy |
H03A |
Thyroid preparations |
H03AA |
Thyroid hormones |
H03AA01 |
levothyroxine* |
H03B |
Antithyroid preparations |
H03BA |
Thiouracils |
H03BA02 |
propylthiouracil |
H03C |
Iodine therapy |
H03CA |
potassium iodide* |
| |
|
J |
ANTIINFECTIVES FOR SYSTEMIC USE |
J01 |
Antibacterials for systemic use |
J01A |
Tetracyclines |
J01AA |
Tetracyclines |
J01AA02 |
doxycycline |
J01B |
Amphenicols |
J01BA |
Amphenicols |
J01BA01 |
chloramphenicol |
J01C |
Beta-lactam antibacterials, penicillins |
J01CA |
Penicillins with extended spectrum |
J01CA01 |
ampicillin |
J01CA04 |
amoxicillin |
J01CE |
Beta-lactamase sensitive penicillins |
J01CE01 |
benzylpenicillin |
J01CE02 |
phenoxymethylpenicillin |
J01CE08 |
benzathine benzylpenicillin |
J01CE09 |
procaine benzylpenicillin* |
J01CF |
Beta-lactamase resistant penicillins |
J01CF02 |
cloxacillin |
J01CR |
Combinations of penicillins, incl. beta-lactamase inhibitors |
J01CR02 |
amoxicillin + clavulanic acid* |
J01D |
Other beta-lactam antibacterials |
J01DA |
Cephalosporins and related substances |
J01DA11 |
ceftazidime |
J01DA13 |
ceftriaxone |
J01DH |
Carbapenems |
J01DH51 |
imipenem + cilastatin* |
J01E |
Sulfonamides and trimethoprim |
J01EA |
Trimethoprim and derivatives |
J01EA01 |
trimethoprim |
J01EC |
Intermediate-acting sulfonamides |
J01EC02 |
sulfadiazine |
J01EE |
Combinations of sulfonamides and trimethoprim, incl. |
| |
derivatives |
J01EE01 |
sulfamethoxazole + trimethoprim |
J01F |
Macrolides, lincosamides and streptogramins |
J01FA |
Macrolides |
J01FA01 |
erythromycin |
J01FF |
Lincosamides |
J01FF01 |
clindamycin |
J01G |
Aminoglycoside antibacterials |
J01GA |
Streptomycins |
J01GA01 |
streptomycin |
J01GB |
Other aminoglycosides |
J01GB03 |
gentamicin |
J01GB04 |
kanamycin |
J01GB06 |
amikacin |
J01M |
Quinolone antibacterials |
J01MA |
Fluoroquinolones |
J01MA01 |
ofloxacin |
J01MA02 |
ciprofloxacin |
J01MA12 |
levofloxacin |
J01MB |
Other quinolones |
J01MB02 |
nalidixic acid |
J01X |
Other antibacterials |
J01XA |
Glycopeptide antibacterials |
J01XA01 |
vancomycin |
J01XD |
Imidazole derivatives |
J01XD01 |
metronidazole |
J01XE |
Nitrofuran derivatives |
J01XE01 |
nitrofurantoin |
J01XX |
Other antibacterials |
J01XX04 |
spectinomycin |
J02 |
Antimycotics for systemic use |
J02A |
Antimycotics for systemic use |
J02AA |
Antibiotics |
J02AA01 |
amphotericin B |
J02AC |
Triazole derivatives |
J02AC01 |
fluconazole |
J02AX |
Other antimycotics for systemic use |
J02AX01 |
flucytosine |
J04 |
Antimycobacterials |
J04A |
Drugs for treatment of tuberculosis |
J04AA |
Aminosalicylic acid and derivatives |
J04AA01 |
p-aminosalicylic acid* |
J04AB |
Antibiotics |
J04AB01 |
cycloserine |
J04AB02 |
rifampicin |
J04AB30 |
capreomycin |
J04AC |
Hydrazides |
J04AC01 |
isoniazid |
J04AD |
Thiocarbamide derivatives |
J04AD03 |
ethionamide |
J04AK |
Other drugs for treatment of tuberculosis |
J04AK01 |
pyrazinamide |
J04AK02 |
ethambutol |
J04AM |
Combinations of drugs for treatment of tuberculosis |
J04AM02 |
rifampicin + isoniazid* |
J04AM02 |
rifampicin + isoniazid + pyrazinamide* |
J04AM02 |
rifampicin + isoniazid + pyrazinamide + ethambutol* |
J04AM03 |
isoniazid + ethambutol* |
J04AM04 |
thioacetazone + isoniazid* |
J04B |
Drugs for treatment of lepra |
J04BA |
Drugs for treatment of lepra |
J04BA01 |
clofazimine |
J04BA02 |
dapsone |
J05 |
Antivirals for systemic use |
J05A |
Direct acting antivirals |
J05AB |
Nucleosides and nucleotides, excl. reverse transcriptase |
| |
inhibitors |
J05AB01 |
aciclovir |
J05AE |
Protease inhibitors |
J05AE01 |
saquinavir (SQV) |
J05AE02 |
indinavir (IDV) |
J05AE03 |
ritonavir(r) |
J05AE04 |
nelfinavir (NFV) |
J05AE30 |
lopinavir + ritonavir (LPV/r)* |
J05AF |
Nucleoside reverse transcriptase inhibitors |
J05AF01 |
zidovudine (ZDV or AZT) |
J05AF02 |
didanosine (ddI) |
J05AF04 |
stavudine (d4T) |
J05AF05 |
lamivudine (3TC) |
J05AF06 |
abacavir (ABC) |
J05AG |
Non-nucleoside reverse transcriptase inhibitors |
J05AG01 |
nevirapine (NVP) |
J05AG03 |
efavirenz (EFV or EFZ) |
J06 |
Immune sera and immunoglobulins |
J06A |
Immune sera |
J06AA |
Immune sera |
J06AA01 |
diphtheria antitoxin |
J06AA03 |
antivenom sera* |
J06B |
Immunoglobulins |
J06BA |
immunoglobulin, human normal |
J06BB |
Specific immunoglobulins |
J06BB01 |
anti-D immunoglobulin (human) |
J06BB02 |
antitetanus immunoglobulin (human)* |
J06BB05 |
rabies immunoglobulin |
J07 |
Vaccines |
J07A |
Bacterial vaccines |
J07AH |
meningococcal meningitis vaccine* |
J07AJ |
Pertussis vaccines |
J07AJ51 |
diphtheria-pertussis-tetanus vaccine* |
J07AM |
Tetanus vaccines |
J07AM51 |
diphtheria-tetanus vaccine* |
J07AN |
Tuberculosis vaccines |
J07AN01 |
BCG vaccine* |
J07AP |
typhoid vaccine |
J07B |
Viral vaccines |
J07BB |
influenza vaccine |
J07BC |
Hepatitis vaccines |
J07BC01 |
hepatitis B vaccine |
J07BD |
Measles vaccine* |
J07BD52 |
measles-mumps-rubella vaccine* |
J07BF |
poliomyelitis vaccine |
J07BG |
rabies vaccine |
J07BJ |
rubella vaccine |
J07BL |
yellow fever vaccine |
| |
|
L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
L01 |
Antineoplastic agents |
L01A |
Alkylating agents |
L01AA |
Nitrogen mustard analogues |
L01AA01 |
cyclophosphamide |
L01AA02 |
chlorambucil |
L01AA05 |
chlormethine |
L01AX |
Other alkylating agents |
L01AX04 |
dacarbazine |
L01B |
Antimetabolites |
L01BA |
Folic acid analogues |
L01BA01 |
methotrexate |
L01BB |
Purine analogues |
L01BB02 |
mercaptopurine |
L01BC |
Pyrimidine analogues |
L01BC01 |
cytarabine |
L01BC02 |
fluorouracil |
L01C |
Plant alkaloids and other natural products |
L01CA |
Vinca alkaloids and analogues |
L01CA01 |
vinblastine |
L01CA02 |
vincristine |
L01CB |
Podophyllotoxin derivatives |
L01CB01 |
etoposide |
L01D |
Cytotoxic antibiotics and related substances |
L01DA |
Actinomycines |
L01DA01 |
dactinomycin |
L01DB |
Anthracyclines and related substances |
L01DB01 |
doxorubicin |
L01DB02 |
daunorubicin |
L01DC |
Other cytotoxic antibiotics |
L01DC01 |
bleomycin |
L01X |
Other antineoplastic agents |
L01XA |
Platinum compounds |
L01XA01 |
cisplatin |
L01XB |
Methylhydrazines |
L01XB01 |
procarbazine |
L01XX |
Other antineoplastic agents |
L01XX02 |
asparaginase |
L02 |
Endocrine therapy |
L02B |
Hormone antagonists and related agents |
L02BA |
Anti-estrogens |
L02BA01 |
tamoxifen |
L04 |
Immunosuppressive agents |
L04A |
Immunosuppressive agents |
L04AA |
Selective immunosuppressive agents |
L04AA01 |
ciclosporin |
L04AX |
Other immunosuppressive agents |
L04AX01 |
azathioprine |
| |
|
M |
MUSCULO-SKELETAL SYSTEM |
M01 |
Antiinflammatory and antirheumatic products |
M01A |
Antiinflammatory and antirheumatic products, |
| |
non-steroids |
M01AE |
Propionic acid derivatives |
M01AE01 |
ibuprofen |
M01C |
Specific antirheumatic agents |
M01CC |
Penicillamine and similar agents |
M01CC01 |
penicillamine |
M03 |
Muscle relaxants |
M03A |
Muscle relaxants, peripherally acting agents |
M03AA |
Curare alkaloids |
M03AA01 |
alcuronium |
M03AB |
Choline derivatives |
M03AB01 |
suxamethonium |
M03AC |
Other quaternary ammonium compounds |
M03AC03 |
vecuronium |
M04 |
Antigout preparations |
M04A |
Antigout preparations |
M04AA |
Preparations inhibiting uric acid production |
M04AA01 |
allopurinol |
M04AC |
Preparations with no effect on uric acid metabolism |
M04AC01 |
colchicine |
| |
|
N |
NERVOUS SYSTEM |
N01 |
Anesthetics |
N01A |
Anesthetics, general |
N01AA |
Ethers |
N01AA01 |
ether, anaesthetic* |
N01AB |
Halogenated hydrocarbons |
N01AB01 |
halothane |
N01AF |
Barbiturates, plain |
N01AF03 |
thiopental |
N01AX |
Other general anesthetics |
N01AX03 |
ketamine |
N01AX13 |
nitrous oxide |
N01B |
Anesthetics, local |
N01BB |
Amides |
N01BB01 |
bupivacaine |
N01BB02 |
lidocaine |
N01BB52 |
lidocaine + epinephrine (adrenaline)* |
N02 |
Analgesics |
N02A |
Opioids |
N02AA |
Natural opium alkaloids |
N02AA01 |
morphine |
N02AB |
Phenylpiperidine derivatives |
N02AB02 |
pethidine |
N02B |
Other analgesics and antipyretics |
N02BA |
Salicylic acid and derivatives |
N02BA01 |
acetylsalicylic acid |
N02BE |
Anilides |
N02BE01 |
paracetamol |
N02C |
Antimigraine preparations |
N02CA |
Ergot alkaloids |
N02CA02 |
ergotamine |
N03 |
Antiepileptics |
N03A |
Antiepileptics |
N03AA |
Barbiturates and derivatives |
N03AA02 |
phenobarbital |
N03AB |
Hydantoin derivatives |
N03AB02 |
phenytoin |
N03AD |
Succinimide derivatives |
N03AD01 |
ethosuximide |
N03AE |
Benzodiazepine derivatives |
N03AE01 |
clonazepam |
N03AF |
Carboxamide derivatives |
N03AF01 |
carbamazepine |
N03AG |
Fatty acid derivatives |
N03AG01 |
valproic acid |
N04 |
Anti-parkinson drugs |
N04A |
Anticholinergic agents |
N04AA |
Tertiary amines |
N04AA02 |
biperiden |
N04B |
Dopaminergic agents |
N04BA |
Dopa and dopa derivatives |
N04BA02 |
levodopa + carbidopa* |
N05 |
Psycholeptics |
N05A |
Antipsychotics |
N05AA |
Phenothiazines with aliphatic side-chain |
N05AA01 |
chlorpromazine |
N05AB |
Phenothiazines with piperazine structure |
N05AB02 |
fluphenazine |
N05AD |
Butyrophenone derivatives |
N05AD01 |
haloperidol |
N05AN |
Lithium |
N05AN01 |
lithium carbonate* |
N05B |
Anxiolytics |
N05BA |
Benzodiazepine derivatives |
N05BA01 |
diazepam |
N05C |
Hypnotics and sedatives |
N05CC |
Aldehydes and derivatives |
N05CC01 |
chloral hydrate |
N06 |
Psychoanaleptics |
N06A |
Antidepressants |
N06AA |
Non-selective monoamine reuptake inhibitors |
N06AA04 |
clomipramine |
N06AA09 |
amitriptyline |
N07 |
Other nervous system drugs |
N07A |
Parasympathomimetics |
N07AA |
Anticholinesterases |
N07AA01 |
neostigmine |
N07AA02 |
pyridostigmine |
| |
|
P |
ANTIPARASITIC PRODUCTS, INSECTICIDES AND |
| |
REPELLENTS |
P01 |
Antiprotozoals |
P01A |
Agents against amoebiasis and other protozoal diseases |
P01AB |
Nitroimidazole derivatives |
P01AB01 |
metronidazole |
P01AC |
Dichloroacetamide derivatives |
P01AC01 |
diloxanide |
P01B |
Antimalarials |
P01BA |
Aminoquinolines |
P01BA01 |
chloroquine |
P01BA03 |
primaquine |
P01BB |
Biguanides |
P01BB01 |
proguanil |
P01BC |
Methanolquinolines |
P01BC01 |
quinine |
P01BC02 |
mefloquine |
P01BD |
Diaminopyrimidines |
P01BD01 |
pyrimethamine |
P01BD51 |
sulfadoxine + pyrimethamine* |
P01BE |
Artemisinin and derivatives |
P01BE02 |
artemether |
P01BE03 |
artesunate |
P01BE52 |
artemether + lumefantrine* |
P01C |
Agents against leishmaniasis and trypanosomiasis |
P01CA |
Nitroimidazole derivatives |
P01CA02 |
benznidazole |
P01CB |
Antimony compounds |
P01CB01 |
meglumine antimoniate |
P01CC |
Nitrofuran derivatives |
P01CC01 |
nifurtimox |
P01CD |
Arsenic compounds |
P01CD01 |
melarsoprol |
P01CX |
Other agents against leishmaniasis and trypanosomiasis |
P01CX01 |
pentamidine* |
P01CX02 |
suramin sodium |
P01CX03 |
eflornithine |
P02 |
Anthelmintics |
P02B |
Antitrematodals |
P02BA |
Quinoline derivatives and related substances |
P02BA01 |
praziquantel |
P02BA02 |
oxamniquine |
P02BX |
Other antitrematodal agents |
PO2BX04a |
triclabendazole |
P02C |
Antinematodal agents |
P02CA |
Benzimidazole derivatives |
P02CA01 |
mebendazole |
P02CA03 |
albendazole |
P02CB |
Piperazine and derivatives |
P02CB02 |
diethylcarbamazine |
P02CC |
Tetrahydropyrimidine derivatives |
P02CC01 |
pyrantel |
P02CE |
Imidazothiazole derivatives |
P02CE01 |
levamisole |
P02CF |
Avermectines |
P02CF01 |
ivermectin |
P02D |
Anticestodals |
P02DA |
Salicylic acid derivatives |
P02DA01 |
niclosamide |
P03 |
Ectoparasiticides, incl. scabicides, insecticides and |
| |
repellents |
P03A |
Ectoparasiticides, incl. scabicides |
P03AC |
Pyrethrines, incl. synthetic compounds |
P03AC04 |
permethrin |
P03AX |
Other ectoparasiticides, incl. scabicides |
P03AX01 |
benzyl benzoate |
P03B |
Insecticides and repellents |
P03BX |
Other insecticides and repellents |
P03BX01 |
diethyltoluamide |
| |
|
R |
RESPIRATORY SYSTEM |
R03 |
Drugs for obstructive airway diseases |
R03A |
Adrenergics, inhalants |
R03AC |
Selective beta-2-adrenoreceptor agonists |
R03AC02 |
salbutamol |
R03B |
Other drugs for obstructive airway diseases, inhalants |
R03BA |
Glucocorticoids |
R03BA01 |
beclometasone |
R03BB |
Anticholinergics |
R03BB01 |
ipratropium bromide |
R03BC |
Antiallergic agents, excl. corticosteroids |
R03BC01 |
cromoglicic acid |
R03C |
Adrenergics for systemic use |
R03CA |
Alpha- and beta-adrenoreceptor agonists |
R03CA02 |
ephedrine |
R03CB |
Non-selective beta-adrenoreceptor agonists |
R03CB01 |
isoprenaline |
R03CC |
Selective beta-2-adrenoreceptor agonists |
R03CC02 |
salbutamol |
R03D |
Other systemic drugs for obstructive airway diseases |
R03DA |
Xanthines |
R03DA04 |
theophylline |
R03DA05 |
aminophylline |
R05 |
Cough and cold preparations |
R05D |
Cough suppressants, excl. combinations with |
| |
expectorants |
R05DA |
Opium alkaloids and derivatives |
R05DA04 |
codeine |
R05DA09 |
dextromethorphan |
R06 |
Antihistamines for systemic use |
R06A |
Antihistamines for systemic use |
R06AB |
Substituted alkylamines |
R06AB04 |
chlorphenamine |
R06AD |
Phenothiazine derivatives |
R06AD02 |
promethazine |
| |
|
S |
SENSORY ORGANS |
S01 |
Ophthalmologicals |
S01A |
Antiinfectives |
S01AA |
Antibiotics |
S01AA09 |
tetracycline |
S01AA11 |
gentamicin |
S01AD |
Antivirals |
S01AD01 |
idoxuridine |
S01B |
Antiinflammatory agents |
S01BA |
Corticosteroids, plain |
S01BA04 |
prednisolone |
S01E |
Antiglaucoma preparations and miotics |
S01EA |
Sympathomimetics in glaucoma therapy |
S01EA01 |
epinephrine |
S01EB |
Parasympathomimetics |
S01EB01 |
pilocarpine |
S01EC |
Carbonic anhydrase inhibitors |
S01EC01 |
acetazolamide |
S01ED |
Beta blocking agents |
S01ED01 |
timolol |
S01F |
Mydriatics and cycloplegics |
S01FA |
Anticholinergics |
S01FA01 |
atropine |
S01FA06 |
tropicamide |
S01H |
Local anesthetics |
S01HA |
Local anesthetics |
S01HA03 |
tetracaine |
S01J |
Diagnostic agents |
S01JA |
Colouring agents |
S01JA01 |
fluorescein |
| |
|
V |
VARIOUS |
V03 |
All other therapeutic products |
V03A |
All other therapeutic products |
V03AB |
Antidotes |
V03AB01 |
ipecacuanha |
V03AB03 |
sodium calcium edetate* |
V03AB06 |
sodium thiosulfate* |
V03AB08 |
sodium nitrite |
V03AB09 |
dimercaprol |
V03AB14 |
protamine sulfate* |
V03AB15 |
naloxone |
V03AB17 |
methylthioninium chloride (methylene blue) |
V03AB23 |
acetylcysteine |
V03AB26 |
DL-methionine* |
V03AB31 |
potassium ferric hexacyanoferrate (II).2H2O (Prussian blue) |
V03AC |
Iron chelating agents |
V03AC01 |
deferoxamine |
V03AF |
Detoxifying agents for antineoplastic treatment |
V03AF03 |
calcium folinate |
V03AN |
Medical gases |
V03AN |
oxygen |
V04 |
Diagnostic agents |
V04C |
Other diagnostic agents |
V04CF |
Tuberculosis diagnostics |
V04CF01 |
tuberculin, purified protein derivative (PPD)* |
V07 |
All other non-therapeutic products |
V07A |
All other non-therapeutic products |
V07AB |
Solvents and diluting agents, incl. irrigating solutions |
V07AB |
water for injection* |
V08 |
Contrast media |
V08A |
X-ray contrast media, iodinated |
V08AA |
Watersoluble, nephrotropic, high osmolar X-ray contrast media |
V08AA01 |
amidotrizoate* |
V08AB |
Watersoluble, nephrotropic, low osmolar X-ray contrast media |
V08AB02 |
iohexol |
V08AC |
Watersoluble, hepatotropic X-ray contrast media |
V08AC02 |
meglumine iotroxate* |
V08AC06 |
iopanoic acid |
V08AD |
Non-watersoluble X-ray contrast media |
V08AD03 |
propyliodone |
V08B |
X-ray contrast media, non-iodinated |
V08BA |
Barium sulfate containing X-ray contrast media |
V08BA01 |
barium sulfate* |